Condition 1: Burn wound. Condition 2: Burn wound.
Conditions
Interventions
Intervention 1: The patients divide two groups: The first one is control group that receive the usual wound care protocol (silver sulfadiazine). Intervention 2: The second group comprising patients th
Treatment - Drugs
The patients divide two groups: The first one is control group that receive the usual wound care protocol (silver sulfadiazine)
The second group comprising patients that receive extracted beta Glucan in local form plus silver ointment
Sponsors
Ministry of Research and Technology Iran University of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: According the similar studies in wound healing by using other imperious agents and attitude skin healing physician in motahari hospital, in this study inclusion criteria are;the age of patients:18-50 years.burn classification: second level and <50% of body surface is burned.Gender;two gender(male , famale) Exclusion criteria: the women with pregnancy; the patients with immunodeficiency, immunosuppression drug consumption; acute infections ;Liver and Kidney diseases .The pateints don’t permit to enter the other clinical trial during this study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease at least 25% wound surface. Timepoint: decreasing the wound size in first week of care,the third day and end of second week and finally end of treatment. Method of measurement: centimeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| TNF Alpha. Timepoint: End of study(8th week). Method of measurement: ELISA and OD.;IFN gamma. Timepoint: End of study(8th week). Method of measurement: ELISA and OD.;IL1. Timepoint: End of study(8th week). Method of measurement: ELISA and OD. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Maryam Roudbary
Iran university of Medical science
Outcome results
None listed